nothing in 2013. nothing is going to cause this stock to have a significant move until the phase III sarcoma trial releases interim data (projected 1st quarter of 2014). quarterly reports mean nothing, phase I data means nothing (in terms of stock price). we need the phase III sarcoma results. that's it.
Twhite, you need to sell and go chase something else. 2014 is such a long long ways off !!! So is the end of 2013 when the phase 3 STS is completely enrolled . After all, the interim OS for the phase 3 STS isn't due until the first half of 2014. That could mean anywhere from January to June of 2014. That's such a long ways off. Might as well sell ! :D